Page last updated: 2024-11-02

pemoline and Claustrophobia

pemoline has been researched along with Claustrophobia in 1 studies

Pemoline: A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.
pemoline : A member of the class of 1,3-oxazoles that is 1,3-oxazol-4(5H)-one which is substituted by an amino group at position 2 and by a phenyl group at position 5. A central nervous system stimulant, it was used to treat hyperactivity disorders in children, but withdrawn from use following reports of serious hepatotoxicity.

Research Excerpts

ExcerptRelevanceReference
"Pemoline was given orally in increasing doses ranging from 20 to 80 mg/day."1.27EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial. ( Barteselli, F; Besana, R; Caresia, L; Guareschi Cazzullo, A; Musetti, L; Pugnetti, L; Scarone, S, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caresia, L1
Pugnetti, L1
Besana, R1
Barteselli, F1
Guareschi Cazzullo, A1
Musetti, L1
Scarone, S1

Other Studies

1 other study available for pemoline and Claustrophobia

ArticleYear
EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial.
    Neuropsychobiology, 1984, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Depressi

1984